A Study to Evaluate the Safety and Tolerability of ILB-202
Clinical trial NCT05843799 · COMPLETED
Trial details
- NCT number
- NCT05843799
- Sponsor
- ILIAS Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-16
- Primary completion
- 2023-10-04
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.